Examination of the “susceptibility gap” in the treatment of canine heartworm infection
Abstract Background The “susceptibility gap” in a dog diagnosed with adult heartworms has been defined as the period of time in which some Dirofilaria immitis stages are not susceptible to treatment with either macrocyclic lactones or melarsomine dihydrochloride. This was previously defined within t...
Main Authors: | Dwight D. Bowman, Jason Drake |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-017-2433-9 |
Similar Items
-
Investigating management choices for canine heartworm disease in northern Mississippi
by: Tobi N. Ku
Published: (2017-11-01) -
Further variation of the adulticide protocol for the treatment of canine heartworm infection: can it be even shorter and cost less?
by: Karen Ann Ward, et al.
Published: (2023-04-01) -
Evaluation of cardiopulmonary and inflammatory markers in dogs with heartworm infection during treatment with the 2014 American Heartworm Society recommended treatment protocol
by: Won-Kyoung Yoon, et al.
Published: (2017-11-01) -
A diagnostic algorithm for evaluating cases of potential macrocyclic lactone–resistant heartworm
by: Andrew R. Moorhead, et al.
Published: (2017-11-01) -
Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline
by: Molly D. Savadelis, et al.
Published: (2017-05-01)